Gilead Sciences GILD
NASDAQ GILD
$144.55 -1.10 (-0.76%)
As of: Sep 10, 2026 · 11:59 AM EDT

Gilead Sciences (GILD) Raw Materials (2009 - 2015)

Gilead Sciences' (GILD) quarterly Raw Materials came in at $1.3 billion in Q4 2015, up 46.53% on a YoY basis from $909.0 million in Q4 2014, and up 46.53% quarter-over-quarter from $909.0 million in Q4 2014.

Analysis

Gilead Sciences (GILD) Raw Materials (2009 - 2015) Analysis & Trends

Gilead Sciences (GILD) has reported Raw Materials for 7 consecutive years, with $1.3 billion the latest figure, recorded in Q4 2015.

  • For the quarter ending Q4 2015, Raw Materials rose 46.53% year-over-year to $1.3 billion; the trailing twelve-month figure through Dec 2015 stood at $1.3 billion (up 46.53% YoY), and the FY2015 full-year result was $1.3 billion, up 46.53% from the prior year.
  • Raw Materials rose to $1.3 billion in Q4 2015 per GILD's latest filing, from $909.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.3 billion in Q4 2015 and bottomed at $559.2 million in Q1 2011.
  • Historically, Raw Materials has averaged $872.3 million across 5 years, with a median of $866.4 million in 2011.
  • The sharpest annual moves came in 2011 and 2014: Raw Materials soared 96.23% in 2011, then dropped 13.38% in 2014.
  • Over 5 years, Raw Materials stood at $697.6 million in 2011, then increased by 18.48% to $826.5 million in 2012, then gained by 26.96% to $1.0 billion in 2013, then decreased by 13.38% to $909.0 million in 2014, then surged by 46.53% to $1.3 billion in 2015.
  • According to Business Quant data, Raw Materials over the past three periods registered $1.3 billion, $909.0 million, and $944.9 million for Q4 2015, Q4 2014, and Q2 2014 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 207.09 Bn 193.10 Bn 7.24 Bn
2 Gilead Sciences 179.68 Bn 176.50 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.39 Bn 123.54 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.79 Bn 73.79 Bn 3.93 Bn
5 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn
6 Moderna 53.35 Bn 48.21 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.40 Bn 30.10 Bn 992.69 Mn
8 Biogen 31.66 Bn 30.38 Bn 1.96 Bn
9 Roivant Sciences 29.14 Bn 29.14 Bn 1.16 Mn
10 Insmed 27.69 Bn 26.53 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.33 Bn
Dec 31, 2014 909.00 Mn
Jun 30, 2014 944.89 Mn
Dec 31, 2013 1.05 Bn
Dec 31, 2012 826.55 Mn
Dec 31, 2011 697.62 Mn
Sep 30, 2011 866.41 Mn
Jun 30, 2011 665.25 Mn
Mar 31, 2011 559.16 Mn
Dec 31, 2010 408.02 Mn
Sep 30, 2010 441.53 Mn
Dec 31, 2009 333.58 Mn